Browsing Bergen Open Research Archive by Author "Damkier, Per"
Now showing items 1-5 of 5
-
Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study
Reppe, Linda Amundstuen; Spigset, Olav; Böttiger, Ylva; Christensen, Hanne Rolighed; Kampmann, Jens Peter; Damkier, Per; Lydersen, Stian; Schjøtt, Jan (Peer reviewed; Journal article, 2014-11)Purpose There is little research-based documentation on the services provided by drug information centres (DICs). The aim of this multi-centre study was to explore for the first time the factors associated with time ... -
Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres
Reppe, Linda Amundstuen; Spigset, Olav; Kampmann, Jens Peter; Damkier, Per; Christensen, Hanne Rolighed; Böttiger, Ylva; Schjøtt, Jan (Peer reviewed; Journal article, 2017-05)Purpose: The aim of this study was to identify structure and language elements affecting the quality of responses from Scandinavian drug information centres (DICs). Methods: Six different fictitious drug-related queries ... -
Relationship Between Time Consumption and Quality of Responses to Drug-Related Queries: A Study From Seven Drug Information Centers in Scandinavia
Reppe, Linda Amundstuen; Lydersen, Stian; Schjøtt, Jan; Damkier, Per; Christensen, Hanne Rolighed; Kampmann, Jens Peter; Böttiger, Ylva; Spigset, Olav (Peer reviewed; Journal article, 2016-07)Purpose: The aims of this study were to assess the quality of responses produced by drug information centers (DICs) in Scandinavia, and to study the association between time consumption processing queries and the quality ... -
Use of References in Responses from Scandinavian Drug Information Centres
Schjøtt, Jan; Böttiger, Ylva; Damkier, Per; Reppe, Linda Amundstuen; Kampmann, Jens Peter; Christensen, Hanne Rolighed; Spigset, Olav (Journal article, 2018)Background: The aim of this study was to compare use of references in responses from Scandinavian drug information centres (DICs). Methods: Six different fictitious drug-related queries were sent to each of seven Scandinavian ... -
Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia
Cesta, Carolyn E.; Segovia Chacón, Silvia; Engeland, Anders; Broe, Anne; Damkier, Per; Furu, Kari; Kieler, Helle; Karlsson, Pär (Journal article; Peer reviewed, 2021)Introduction For phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil, the only approved indication in women is for pulmonary arterial hypertension. These drugs are increasingly being proposed and tested for ...